Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Recombinant Human Cathepsin Z protein (His tag) (ab276214)

Recombinant Human Cathepsin Z protein (His tag) (ab276214)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: HEK 293 cells
  • Purity: > 97% SDS-PAGE
  • Endotoxin level:
  • Tags: His tag C-Terminus
  • Suitable for: SDS-PAGE

You may also be interested in

Product image
Anti-Histone H2B antibody [EP957Y] (ab52599)
Product image
Anti-cAMP Protein Kinase Catalytic subunit antibody (ab96186)
Product image
Anti-G-CSF antibody [CSF3/900] (ab216607)
9(Z),11(E)-Octadecadienoic acid, Conjugated linoleic acid (ab143913)

Preparation and Storage

  • Carboxypeptidase LB
  • Cathepsin B2
  • Cathepsin IV

Images

  • SDS-PAGE - Recombinant Human Cathepsin Z protein (ab276214)
    SDS-PAGE - Recombinant Human Cathepsin Z protein (ab276214)
    SDS-PAGE analysis of ab276214

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Alanine Transaminase antibody (ab236658)

  •  
  • Biotin Anti-beta Amylase antibody (ab182902)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.